Environmental Toxins: Exposure to heavy metals, pesticides, and air pollution uses up glutathione quickly as the body tries to detoxify
Andrea Corona MapLight reports mixed results in Schizophrenia trial In their Phase 2 ZEPHR trial, MapLights novel oral drug for schizophrenia, the Ml/M4 muscarinic agonist ML-007C-MA, successfully hit its primary endpoint but only for the twice-daily version, not the once-daily dose
To determine whether your insurance will cover vitamin B12 injections provided by our team, we encourage you to contact your insurance carrier directly
The 503A evaluation uses a balancing test, not the new-drug approval standard
Theyre commonly used for procedures like blood draws or delivering IV fluids and medication
BPC-157 peptide therapy may be suitable for adults seeking relief from musculoskeletal pain or injuries, joint concerns, digestive issues, chronic inflammation, or central nervous system (CNS) disorders.8 11 It could also potentially be used for neuroprotection, nerve regeneration, repairing organ damage from substance overdoses, healing lesions, and more.7 However, its again important to reiterate that nearly all of the above potential benefits of BPC-157 have not been demonstrated in human studies or trials